Dual and Recombinant Infections in HIV-1 Epidemic in Brazil
Author Information
Author(s): Artur Ramos, Amilcar Tanuri, Mauro Schechter, Mark A. Rayfield, Dale J. Hu, Maulori C. Cabral, Claudiu I. Bandea, James Baggs, Danuta Pieniazek
Primary Institution: Centers for Disease Control and Prevention, Atlanta, Georgia, USA; Universidade Federal do Rio de Janeiro, Brazil; Emory University, Atlanta, Georgia, USA
Hypothesis
What is the prevalence of dual and recombinant HIV-1 infections among HIV-infected individuals in Brazil?
Conclusion
Dual and recombinant infections are emerging as an integral part of the HIV/AIDS epidemic in Brazil.
Supporting Evidence
- 3.8% of the participants had dual infections.
- 7.6% of the participants had recombinant infections.
- 88.6% of infections involved single viral subtypes.
- Mixed infections may influence the dynamics of the HIV/AIDS pandemic.
- Genetic variation from mixed infections could lead to new HIV variants.
Takeaway
Some people with HIV in Brazil have infections from more than one type of the virus, which can change how the disease spreads.
Methodology
The study used molecular screening assays and DNA sequencing to evaluate HIV-1 infections in a clinical cohort study.
Limitations
The study may not capture all mixed infections due to detection limitations and the potential for underreporting.
Participant Demographics
Participants were HIV-1 infected individuals from Rio de Janeiro, Brazil, with a mix of genders and ages.
Want to read the original?
Access the complete publication on the publisher's website